TRAZIMERA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: f0fda67a5441e98b
Drug Approval Canada Name: TRAZIMERA
Product Name: TRAZIMERA
Status: Marketed
Status Date: 2019-10-22
Original Market Date: 2019-10-22
Din: 02483467
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FD01 TRASTUZUMAB
Atc Name: l 01 fd 01
Aig Number: 0154252001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

TRASTUZUMAB

440 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f0fda67a5441e98b

Type

Standard